Alcohol study discarded by Trump officials is published in scientific journal - Scorecard - MDSpire

Alcohol study discarded by Trump officials is published in scientific journal

  • By

  • Isabella Cueto

  • June 9, 2026

  • 0 min

Share

Clinical Scorecard: Federal Alcohol Health Effects Study, Previously Shelved by Trump Administration, Released in Scientific Journal

At a Glance

CategoryDetail
Condition
Key MechanismsSpecify types of diseases and mortality associated with alcohol consumption.
Target Population
Care Setting

Key Highlights

  • Remove unsupported claim about 'no net health benefit' unless directly sourced.

Guideline-Based Recommendations

Diagnosis

    Management

    • R
    • e
    • v
    • i
    • s
    • e
    • t
    • o
    • i
    • n
    • c
    • l
    • u
    • d
    • e
    • o
    • n
    • l
    • y
    • r
    • e
    • c
    • o
    • m
    • m
    • e
    • n
    • d
    • a
    • t
    • i
    • o
    • n
    • s
    • d
    • i
    • r
    • e
    • c
    • t
    • l
    • y
    • s
    • t
    • a
    • t
    • e
    • d
    • i
    • n
    • t
    • h
    • e
    • s
    • o
    • u
    • r
    • c
    • e
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Adults who consume alcohol.

        Risks associated with alcohol consumption vary by gender and amount consumed.

        Clinical Best Practices

        • practices

        Related Resources & Content

        Original Source(s)

        Alcohol study discarded by Trump officials is published in scientific journal

        • by Isabella Cueto

        • June 9, 2026

        Related Content

        Can Finerenone Alter Glomerular Disease Trajectory?

        A prespecified exploratory analysis of the FIND-CKD clinical trial examined kidney function, albuminuria, and kidney failure outcomes in 903 patients with glomerular diseases.

        Electroacupuncture at LI11 and SP10 is associated with alleviation of acute urticaria-like reactions in passive cutaneous anaphylaxis: an exploratory analysis of complement-related proteins and multiscale omics

        Evaluating the efficacy and safety of first-line immunotherapy for metastatic triple-negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials with a focus on PD-L1 expression